Provided by Tiger Trade Technology Pte. Ltd.

Achieve Life Sciences, Inc.

2.90
-1.1500-28.40%
Post-market: 2.900.0001+0.00%16:40 EDT
Volume:4.38M
Turnover:13.89M
Market Cap:154.38M
PE:-2.15
High:3.74
Open:3.66
Low:2.85
Close:4.05
52wk High:6.03
52wk Low:1.84
Shares:53.23M
Float Shares:44.42M
Volume Ratio:12.40
T/O Rate:9.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3500
EPS(LYR):-1.2418
ROE:-161.08%
ROA:-65.45%
PB:4.59
PE(LYR):-2.34

Loading ...

Achieve Life Sciences Inc - Pdufa Date for Cytisinicline Set for June 20, 2026

THOMSON REUTERS
·
Nov 06, 2025

Achieve Life Sciences Q3 Net Income USD -14.441 Million VS. Ibes Estimate USD -12.2 Million

THOMSON REUTERS
·
Nov 06, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 06, 2025

Achieve Life Sciences Unveils Cytisinicline Strategy Targeting Nicotine Dependence Market

Reuters
·
Nov 05, 2025

Achieve Life Sciences Inc expected to post a loss of 26 cents a share - Earnings Preview

Reuters
·
Nov 04, 2025

Achieve Life Sciences announces several milestones in its ORCA-OL trial

TIPRANKS
·
Nov 03, 2025

Achieve Life Sciences Inc - Dsmc Finds No Serious Adverse Events in Orca-Ol Trial

THOMSON REUTERS
·
Nov 03, 2025

Achieve Life Sciences Inc: Dsmc Found No Concerns With Respect to Drug Safety

THOMSON REUTERS
·
Nov 03, 2025

Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline Nda for Smoking Cessation

THOMSON REUTERS
·
Nov 03, 2025

Achieve Life Sciences Inc. Files Initial Statement of Beneficial Ownership for Chief Legal Officer Erik Atkisson

Reuters
·
Oct 22, 2025

4 Biotech Stocks Lifting Off As Momentum Builds

Benzinga_recent_news
·
Oct 21, 2025

Press Release: Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer

Dow Jones
·
Oct 20, 2025

Achieve Life Sciences (ACHV) Is Up 36.4% After FDA Awards Rare Priority Voucher for Vaping Cessation Drug – Has the Bull Case Changed?

Simply Wall St.
·
Oct 20, 2025

Achieve Life Sciences (ACHV) Gets a Buy from Raymond James

TIPRANKS
·
Oct 18, 2025

BUZZ-U.S. STOCKS ON THE MOVE- SLB NV, Bank OZK, Gilead Sciences

Reuters
·
Oct 18, 2025

FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times

Benzinga_recent_news
·
Oct 17, 2025

Shares of Some US Drug Developers up After FDA Announces Recipients of National Priority Vouchers

THOMSON REUTERS
·
Oct 17, 2025

Revolution Medicines up 6%, Achieve Life Sciences up 22.1%, Disc Medicine up 19.2%

THOMSON REUTERS
·
Oct 17, 2025

BRIEF-Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher For Cytisinicline For Treatment Of Nicotine Dependence For E-Cigarette Or Vaping Cessation

Reuters
·
Oct 17, 2025

Achieve Life Sciences Inc - FDA-Assessment Time Reduced to 1-2 Months for Cytisinicline

THOMSON REUTERS
·
Oct 17, 2025